Kevin Stefanski

1.5k total citations
16 papers, 734 citations indexed

About

Kevin Stefanski is a scholar working on Pharmaceutical Science, Biomaterials and Materials Chemistry. According to data from OpenAlex, Kevin Stefanski has authored 16 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 3 papers in Biomaterials and 3 papers in Materials Chemistry. Recurrent topics in Kevin Stefanski's work include Drug Solubulity and Delivery Systems (8 papers), Advancements in Transdermal Drug Delivery (4 papers) and Advanced Drug Delivery Systems (4 papers). Kevin Stefanski is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Advancements in Transdermal Drug Delivery (4 papers) and Advanced Drug Delivery Systems (4 papers). Kevin Stefanski collaborates with scholars based in United States, China and Germany. Kevin Stefanski's co-authors include Michael J. Hageman, Roy Haskell, Feng Qian, Munir Hussain, Ching Su, Yuejie Chen, Tiehua Huang, Qun Lu, Ping Gao and Chengyu Liu and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Kevin Stefanski

16 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Stefanski United States 9 504 270 130 103 85 16 734
Roy Haskell United States 12 483 1.0× 266 1.0× 129 1.0× 101 1.0× 51 0.6× 19 655
Bong-Kyu Yoo South Korea 12 384 0.8× 143 0.5× 95 0.7× 52 0.5× 43 0.5× 19 538
Seh Hyon Song South Korea 12 314 0.6× 69 0.3× 75 0.6× 40 0.4× 34 0.4× 16 447
In-Joon Oh South Korea 15 346 0.7× 77 0.3× 155 1.2× 58 0.6× 101 1.2× 30 636
V. Kusum Devi India 13 369 0.7× 194 0.7× 95 0.7× 40 0.4× 78 0.9× 28 778
Magda W. Samaha Egypt 14 358 0.7× 96 0.4× 193 1.5× 45 0.4× 68 0.8× 24 825
Urban Skantze Sweden 10 327 0.6× 178 0.7× 83 0.6× 88 0.9× 88 1.0× 13 598
M. Ghorab Egypt 11 774 1.5× 91 0.3× 146 1.1× 46 0.4× 88 1.0× 17 989
Scott V. Jermain United States 10 444 0.9× 225 0.8× 105 0.8× 124 1.2× 41 0.5× 10 596
Sayed M. Ahmed Egypt 12 361 0.7× 64 0.2× 100 0.8× 42 0.4× 57 0.7× 22 523

Countries citing papers authored by Kevin Stefanski

Since Specialization
Citations

This map shows the geographic impact of Kevin Stefanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Stefanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Stefanski more than expected).

Fields of papers citing papers by Kevin Stefanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Stefanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Stefanski. The network helps show where Kevin Stefanski may publish in the future.

Co-authorship network of co-authors of Kevin Stefanski

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Stefanski. A scholar is included among the top collaborators of Kevin Stefanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Stefanski. Kevin Stefanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Foster, Kimberly A., et al.. (2022). Enhanced aqueous dissolution of hydrophobic apixaban via direct incorporation of hydrophilic nanographene oxide. Colloids and Surfaces B Biointerfaces. 216. 112512–112512. 6 indexed citations
2.
Mosquera-Giraldo, Laura I., Kevin Stefanski, Kimberly A. Foster, et al.. (2021). Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration. Pharmaceutical Research. 38(5). 901–914. 3 indexed citations
3.
Foster, Kimberly A., et al.. (2021). Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate. Molecules. 26(7). 1972–1972. 3 indexed citations
4.
Zhao, Qihong, Anwar Murtaza, Ragini Vuppugalla, et al.. (2018). Abstract 3760: Preclinical antitumor activity of a CC chemokine receptor (CCR) 2/5 dual antagonist as monotherapy and in combination with immune checkpoint blockade. Cancer Research. 78(13_Supplement). 3760–3760. 8 indexed citations
5.
Chen, Huijun, Chengyu Liu, Zhen Chen, et al.. (2017). Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance. Journal of Pharmaceutical Sciences. 107(1). 317–326. 60 indexed citations
6.
Bhide, Rajeev S., Zheming Ruan, Carolyn A. Weigelt, et al.. (2016). Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(17). 4256–4260. 12 indexed citations
7.
Huang, Yande, et al.. (2016). Dehydration and Stabilization of a Reactive Tertiary Hydroxyl Group in Solid Oral Dosage Forms of BMS-779788. Journal of Pharmaceutical Sciences. 105(4). 1478–1488. 1 indexed citations
8.
Chen, Yuejie, Shujing Wang, Shan Wang, et al.. (2016). Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction. Pharmaceutical Research. 33(10). 2445–2458. 106 indexed citations
9.
Discenza, Lorell, Georgia Cornelius, Jinping Gan, et al.. (2016). Ultrasensitive Quantitative LC–MS/MS of an Inhibitor of Apoptosis Protein’s Antagonist in Plasma Using Protein Target Affinity Extraction. Bioanalysis. 8(4). 265–274. 3 indexed citations
10.
Chen, Yuejie, Shujing Wang, Shan Wang, et al.. (2016). Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion. Molecular Pharmaceutics. 13(8). 2787–2795. 65 indexed citations
11.
Chen, Xueqing, Kevin Stefanski, Hong Shen, et al.. (2014). Oral Delivery of Highly Lipophilic Poorly Water-Soluble Drugs: Spray-Dried Dispersions to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a P2Y1 Antagonist. Journal of Pharmaceutical Sciences. 103(12). 3924–3931. 14 indexed citations
12.
Chen, Yuejie, Chengyu Liu, Zhen Chen, et al.. (2014). Drug–Polymer–Water Interaction and Its Implication for the Dissolution Performance of Amorphous Solid Dispersions. Molecular Pharmaceutics. 12(2). 576–589. 150 indexed citations
13.
Larsen, Scott D., Zhi‐Jun Zhang, Peter R. Manninen, et al.. (2007). 7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: Synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase. Bioorganic & Medicinal Chemistry Letters. 17(14). 3840–3844. 8 indexed citations
14.
Gao, Ping, et al.. (2004). Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations. Drug Development and Industrial Pharmacy. 30(2). 221–229. 176 indexed citations
15.
Romero, Donna L., Robert A. Olmsted, Toni J. Poel, et al.. (1996). Targeting Delavirdine/Atevirdine Resistant HIV-1:  Identification of (Alkylamino)piperidine-Containing Bis(heteroaryl)piperazines as Broad Spectrum HIV-1 Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 39(19). 3769–3789. 50 indexed citations
16.
Buhl, Allen E., Daniel J. Waldon, Marc F. Kubicek, et al.. (1992). Potassium Channel Conductance: A Mechanism Affecting Hair Growth both In Vitro and In Vivo. Journal of Investigative Dermatology. 98(3). 315–319. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026